Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 117.81% | 117.95% | -80.57% | -80.86% | -276.94% |
| Total Depreciation and Amortization | 4.88% | 5.72% | -1.43% | -2.92% | 0.80% |
| Total Amortization of Deferred Charges | 86.29% | 87.77% | 138.26% | 134.64% | 88.11% |
| Total Other Non-Cash Items | -93.67% | -93.62% | 109.45% | 109.31% | 688.41% |
| Change in Net Operating Assets | 90.67% | 90.60% | -- | -- | -1,237.82% |
| Cash from Operations | 127.67% | 129.48% | 1,118.77% | 1,103.36% | -65.73% |
| Capital Expenditure | 25.85% | 25.25% | -- | -- | -38.71% |
| Sale of Property, Plant, and Equipment | -57.51% | -57.17% | -- | -- | 42,572.92% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -31.52% | -30.97% | -- | -- | -- |
| Other Investing Activities | -845.01% | -850.95% | -195.20% | -193.76% | 156.74% |
| Cash from Investing | -146.14% | -148.11% | -128.77% | -128.33% | 39.55% |
| Total Debt Issued | -56.92% | -56.92% | 60.65% | 60.65% | 62.36% |
| Total Debt Repaid | 20.67% | 20.67% | -21.37% | -21.37% | 19.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -19.25% | -19.25% | -719.36% | -719.36% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.87% | 3.11% | -- | -- | -5.44% |
| Other Financing Activities | 42.53% | 42.53% | 1,746.89% | 1,746.89% | -2.47% |
| Cash from Financing | -69.69% | -71.04% | 157.24% | 156.38% | 12.23% |
| Foreign Exchange rate Adjustments | -7.69% | -6.92% | -80.82% | -81.14% | -86.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -85.24% | -86.72% | -8.26% | -9.65% | -108.11% |